Citation 87168

NOGAWA,T: KAMANO,Y: YAMASHITA,A: PETTIT,GR:. (2001). ISOLATION AND STRUCTURE OF FIVE NEW CANCER CELL GROWTH INHIBITORY BUFADIENOLIDES FROM THE CHINESE TRADITIONAL DRUG CH'AN SU.. 64(9)

Citation Details

Title	ISOLATION AND STRUCTURE OF FIVE NEW CANCER CELL GROWTH INHIBITORY BUFADIENOLIDES FROM THE CHINESE TRADITIONAL DRUG CH'AN SU.
Authors	NOGAWA,T: KAMANO,Y: YAMASHITA,A: PETTIT,GR:
Year	2001
Volume	64
Issue	9

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Bufo gargarizans (BUFONIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RESIBUFOGENIN-3-FORMATE	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN-3-FORMATE	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN-3-FORMATE	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN-3-FORMATE	WEAK ACTIVITY
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN-3-FORMATE	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN-3-FORMATE	STRONG ACTIVITY
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN-3-FORMATE	STRONG ACTIVITY
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN-3-FORMATE	STRONG ACTIVITY
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN-3-FORMATE	STRONG ACTIVITY
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN-3-FORMATE	STRONG ACTIVITY
11	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BUFALIN,19-OXO:	None
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,19-OXO:	STRONG ACTIVITY
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,19-OXO:	INACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,19-OXO:	STRONG ACTIVITY
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,19-OXO:	STRONG ACTIVITY
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,19-OXO:	STRONG ACTIVITY
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,19-OXO:	STRONG ACTIVITY
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,19-OXO:	STRONG ACTIVITY
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,19-OXO:	STRONG ACTIVITY
20	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CINOBUFAGIN,DEACETYL: 19-OXO:	None
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL: 19-OXO:	STRONG ACTIVITY
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL: 19-OXO:	ACTIVE
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL: 19-OXO:	INACTIVE
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL: 19-OXO:	INACTIVE
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL: 19-OXO:	INACTIVE
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL: 19-OXO:	INACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL: 19-OXO:	INACTIVE
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL: 19-OXO:	INACTIVE
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL: 19-OXO:	INACTIVE
30	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CINOBUFAGIN,6-ALPHA-HYDROXY:	None
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,6-ALPHA-HYDROXY:	STRONG ACTIVITY
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,6-ALPHA-HYDROXY:	STRONG ACTIVITY
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,6-ALPHA-HYDROXY:	INACTIVE
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,6-ALPHA-HYDROXY:	STRONG ACTIVITY
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,6-ALPHA-HYDROXY:	STRONG ACTIVITY
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,6-ALPHA-HYDROXY:	STRONG ACTIVITY
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,6-ALPHA-HYDROXY:	STRONG ACTIVITY
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,6-ALPHA-HYDROXY:	STRONG ACTIVITY
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,6-ALPHA-HYDROXY:	STRONG ACTIVITY
40	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BUFALIN,1-BETA-HYDROXY:	None
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,1-BETA-HYDROXY:	STRONG ACTIVITY
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,1-BETA-HYDROXY:	STRONG ACTIVITY
43	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,1-BETA-HYDROXY:	INACTIVE
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,1-BETA-HYDROXY:	STRONG ACTIVITY
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,1-BETA-HYDROXY:	STRONG ACTIVITY
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,1-BETA-HYDROXY:	STRONG ACTIVITY
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,1-BETA-HYDROXY:	STRONG ACTIVITY
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,1-BETA-HYDROXY:	STRONG ACTIVITY
49	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN,1-BETA-HYDROXY:	STRONG ACTIVITY
50	Not specified	ISOLATION AND IDENTIFICATION OF	BUFOTALIN,5-BETA-HYDROXY:	None
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN,5-BETA-HYDROXY:	STRONG ACTIVITY
52	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN,5-BETA-HYDROXY:	STRONG ACTIVITY
53	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN,5-BETA-HYDROXY:	INACTIVE
54	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN,5-BETA-HYDROXY:	STRONG ACTIVITY
55	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN,5-BETA-HYDROXY:	STRONG ACTIVITY
56	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN,5-BETA-HYDROXY:	STRONG ACTIVITY
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN,5-BETA-HYDROXY:	STRONG ACTIVITY
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN,5-BETA-HYDROXY:	STRONG ACTIVITY
59	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN,5-BETA-HYDROXY:	STRONG ACTIVITY
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,19-HYDROXY:	ACTIVE
61	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,19-HYDROXY:	STRONG ACTIVITY
62	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,19-HYDROXY:	INACTIVE
63	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,19-HYDROXY:	STRONG ACTIVITY
64	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,19-HYDROXY:	STRONG ACTIVITY
65	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,19-HYDROXY:	STRONG ACTIVITY
66	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,19-HYDROXY:	STRONG ACTIVITY
67	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,19-HYDROXY:	STRONG ACTIVITY
68	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,19-HYDROXY:	STRONG ACTIVITY
69	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,12-BETA-HYDROXY:	STRONG ACTIVITY
70	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,12-BETA-HYDROXY:	STRONG ACTIVITY
71	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,12-BETA-HYDROXY:	INACTIVE
72	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,12-BETA-HYDROXY:	STRONG ACTIVITY
73	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,12-BETA-HYDROXY:	STRONG ACTIVITY
74	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,12-BETA-HYDROXY:	STRONG ACTIVITY
75	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,12-BETA-HYDROXY:	STRONG ACTIVITY
76	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,12-BETA-HYDROXY:	STRONG ACTIVITY
77	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN,12-BETA-HYDROXY:	STRONG ACTIVITY
78	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGENIN,12-BETA-HYDROXY:	STRONG ACTIVITY
79	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGENIN,12-BETA-HYDROXY:	STRONG ACTIVITY
80	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGENIN,12-BETA-HYDROXY:	INACTIVE
81	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL: 19-HYDROXY:	ACTIVE
82	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL: 19-HYDROXY:	STRONG ACTIVITY
83	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL: 19-HYDROXY:	INACTIVE
84	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN	ACTIVE
85	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN	STRONG ACTIVITY
86	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESIBUFOGENIN	WEAK ACTIVITY
87	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN	STRONG ACTIVITY
88	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN	STRONG ACTIVITY
89	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN	INACTIVE
90	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL:	STRONG ACTIVITY
91	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL:	ACTIVE
92	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFAGIN,DEACETYL:	INACTIVE
93	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFOTALIN	STRONG ACTIVITY
94	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFOTALIN	STRONG ACTIVITY
95	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFOTALIN	INACTIVE
96	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFOTALIN,DEACETYL:	WEAK ACTIVITY
97	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFOTALIN,DEACETYL:	ACTIVE
98	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINOBUFOTALIN,DEACETYL:	INACTIVE
99	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN	STRONG ACTIVITY
100	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN	STRONG ACTIVITY
101	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFALIN	INACTIVE
102	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN	STRONG ACTIVITY
103	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN	STRONG ACTIVITY
104	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN	STRONG ACTIVITY
105	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN,DEACETYL:	STRONG ACTIVITY
106	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN,DEACETYL:	STRONG ACTIVITY
107	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BUFOTALIN,DEACETYL:	INACTIVE
108	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TELOCINOBUFAGIN	ACTIVE
109	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TELOCINOBUFAGIN	STRONG ACTIVITY
110	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TELOCINOBUFAGIN	INACTIVE
111	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GAMABUFOTALIN	STRONG ACTIVITY
112	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GAMABUFOTALIN	STRONG ACTIVITY
113	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GAMABUFOTALIN	INACTIVE

Citation 87168

Citation Details

Summary

Organisms and Their Experiments (1)

Bufo gargarizans (BUFONIDAE)

Show SPARQL Queries (1)

Query 1